换一批Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies.
第一作者：
Alimuddin,Zumla
第一单位：
Division of Infection and Immunity, University College London and National Institute for Health Research (NIHR) Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK; UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia. Electronic address: a.zumla@ucl.ac.uk.
作者：
医学主题词
佐剂, 免疫(Adjuvants, Immunologic);抗HIV药(Anti-HIV Agents);抗结核药(Antitubercular Agents);临床方案(Clinical Protocols);药物发现(Drug Discovery);药物疗法, 联合(Drug Therapy, Combination);HIV感染(HIV Infections);人类(Humans);结核分枝杆菌(Mycobacterium tuberculosis);诊疗准则(主题)(Practice Guidelines as Topic);随机对照试验(主题)(Randomized Controlled Trials as Topic);结核, 抗多种药物性(Tuberculosis, Multidrug-Resistant);世界卫生组织(World Health Organization)
DOI
10.1016/S2213-2600(15)00063-6
PMID
25773212
发布时间
2022-04-10
- 浏览44
The Lancet. Respiratory medicine
2015年3卷3期
220-34页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
